Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Lithium was associated with a higher risk of thyroid and kidney ...

This is the fifth post in a series on non-pharmacologic treatments of bipolar disorder. Previous posts briefly reviewed the evidence for amino acids, the B vitamin choline, and a proprietary nutrient ...

Lithium carbonate and valproate sodium are each recommended as monotherapy for preventing relapses in patients with bipolar disorder and are sometimes used in combination. However, combination therapy ...

Hayes et al 12 conducted one of the most recent large studies to compare lithium with newer second-generation antipsychotics as maintenance monotherapy for bipolar disorder. The authors concluded that ...

July 25, 2011 — Lithium is more effective in treating episodes of bipolar disorder (BD) than valproate. However, there is little difference between the 2 agents in reducing suicidality in this patient ...

The lead researcher from HKUMed, Dr Chang Wing-chung (centre), highlights that the study reinforces the therapeutic value of lithium, showing its safe use in managing bipolar disorder with proper ...

Lithium restored microcephaly, abnormal synaptic function, and communication issues in mice with Dyrk1a deficiency, a gene associated with autism and Dyrk1a syndrome, to normal levels. A ...

Higher lithium serum levels linked to elevated rates of hypothyroidism, hyperthyroidism, and CKD3+. (HealthDay News) — Lithium is associated with an increased risk for thyroid dysfunction and chronic ...

Compared with lithium, valproate, olanzapine, quetiapine, and risperidone generally exhibited a lower likelihood of thyroid dysfunction. HealthDay News — Lithium is associated with an increased risk ...